DarioHealth Corp. Adjustments to Additional Paid in Capital, Warrant Issued
DarioHealth Corp. (DRIO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $2.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-19
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $465.00K, a 73.85% decline year-over-year.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $211.00K, a 58.87% decline year-over-year.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $2.00M, a 236.30% increase year-over-year.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $27.00K, a 95.71% decline year-over-year.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $2.70M, a 23.09% decline from fiscal 2023.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $3.52M, a 13.24% increase from fiscal 2022.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $3.10M, a 54.45% decline from fiscal 2021.
- DarioHealth Corp. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $6.82M, a 358.44% increase from fiscal 2020.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-12-31 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $676.00K derived: sum of 2 quarters · filed 2026-03-19 | $2.68M derived: sum of 3 quarters · filed 2026-03-19 | $2.70M 10-K · filed 2026-03-19 |
| 2024-09-30 | $211.00K 10-Q · filed 2025-11-13 | $2.21M derived: sum of 2 quarters · filed 2025-11-13 | $2.24M 10-Q · filed 2025-11-13 | $4.02M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-12 | $2.03M 10-Q · filed 2025-08-12 | $3.81M derived: sum of 3 quarters · filed 2025-08-12 | $4.32M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $27.00K 10-Q · filed 2025-05-14 | $1.80M derived: sum of 2 quarters · filed 2025-05-14 | $2.32M derived: sum of 3 quarters · filed 2025-05-14 | $2.91M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $2.29M derived: sum of 2 quarters · filed 2025-03-10 | $2.89M derived: sum of 3 quarters · filed 2025-03-10 | $3.52M 10-K · filed 2025-03-10 |
| 2023-09-30 | $513.00K 10-Q · filed 2024-11-07 | $1.11M derived: sum of 2 quarters · filed 2024-11-07 | $1.74M 10-Q · filed 2024-11-07 | $2.38M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $595.00K 10-Q · filed 2024-08-08 | $1.23M 10-Q · filed 2024-08-08 | $1.86M derived: sum of 3 quarters · filed 2024-08-08 | $2.47M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $630.00K 10-Q · filed 2024-05-15 | $1.27M derived: sum of 2 quarters · filed 2024-05-15 | $1.88M derived: sum of 3 quarters · filed 2024-05-15 | $2.43M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.25M derived: sum of 2 quarters · filed 2024-03-28 | $1.80M derived: sum of 3 quarters · filed 2024-03-28 | $3.10M 10-K · filed 2024-03-28 |
| 2022-09-30 | $609.00K 10-Q · filed 2023-11-02 | $1.17M derived: sum of 2 quarters · filed 2023-11-02 | $2.47M 10-Q · filed 2023-11-02 | $4.37M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $557.00K 10-Q · filed 2023-08-10 | $1.86M 10-Q · filed 2023-08-10 | $3.76M derived: sum of 3 quarters · filed 2023-08-10 | $5.88M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.30M 10-Q · filed 2023-05-11 | $3.20M derived: sum of 2 quarters · filed 2023-05-11 | $5.32M derived: sum of 3 quarters · filed 2023-05-11 | $7.27M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.02M derived: sum of 2 quarters · filed 2023-03-09 | $5.97M derived: sum of 3 quarters · filed 2023-03-09 | $6.82M 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.12M 10-Q · filed 2022-11-14 | $4.07M derived: sum of 2 quarters · filed 2022-11-14 | $4.92M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.95M 10-Q · filed 2022-08-15 | $2.80M derived: sum of 2 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $846.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $1.49M 10-K · filed 2022-03-22 | |||
| 2020-09-30 | $90.00K 10-Q · filed 2021-11-15 | $240.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.37M derived: sum of 3 quarters · filed 2021-11-15 | |
| 2020-06-30 | $150.00K 10-Q · filed 2021-11-15 | $1.28M derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | $1.13M 10-Q · filed 2021-11-15 | |||
| 2015-12-31 | $822.00K 10-K · filed 2017-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |